Drug Type Small molecule drug |
Synonyms- |
Action agonists, inhibitors |
Mechanism Adiponectin receptors agonists, NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Phase 3 | Mexico | - | 01 Apr 2022 |
Gram-Negative Bacterial Infections | Preclinical | China | 05 Apr 2023 | |
Bacillaceae Infections | Preclinical | Iran | 13 Apr 2010 | |
Escherichia Coli Infections | Preclinical | Iran | 13 Apr 2010 | |
Pseudomonas aeruginosa infection | Preclinical | Iran | 13 Apr 2010 | |
Staphylococcus Aureus Infections | Preclinical | Iran | 13 Apr 2010 |
Not Applicable | 18 | nothorbosi(aduqkkcbec) = bmvldlpsic muopvkzbxr (wxosfblbtl ) View more | - | 01 Sep 2013 | |||
Saline | nothorbosi(aduqkkcbec) = nvqzozvdir muopvkzbxr (wxosfblbtl ) View more |